Skip to main content
. 2022 Jun 7;17:147. doi: 10.1186/s13019-022-01903-w

Table 3.

Summary of Follow up Outcomes Comparing HCR and CABG

Subgroup No. of studies OR 95%CI p I2 (%) Effect-model
One-year
MACCE 6 1.35 0.73–2.49 0.34 0 Fixed
Death 5 1.32 0.47–3.70 0.59 0 Fixed
Myocardial infarction 6 1.31 0.64–2.70 0.46 0 Fixed
Repeat revascularization 6 3.28 1.62–6.64  < 0.001 0 Fixed
Stroke 2 3.73 0.60–23.02 0.16 0 Fixed
Within one to five year
MACCE 4 1.25 0.53–2.97 0.61 64 Random
Neurologic event 2 0.29 0.07–1.15 0.08 22 Fixed
Death 3 1.90 0.66–5.48 0.24 0 Fixed
Myocardial infarction 3 1.18 0.44–3.14 0.74 33 Fixed
Repeat revascularization 4 2.84 1.64–4.92  < 0.001 0 Fixed
Five-year
MACCE 3 0.93 0.61–1.41 0.72 25 Fixed
Death 3 0.35 0.18–0.69 0.002 15 Fixed
Myocardial infarction 3 0.83 0.34–2.04 0.68 0 Fixed
Repeat revascularization 4 1.05 0.71–1.53 0.82 7 Fixed
Stroke 2 0.57 0.16–2.01 0.39 0 Fixed

HCR, hybrid coronary revascularization; CABG, coronary artery bypass grafting; OR, odds ratio; CI, confidence interval; MACCE, major adverse cardiac or cerebrovascular events; ICU LOS, intensive care unit length of stay